Key cost drivers of pharmaceutical clinical trials in the United States

  title={Key cost drivers of pharmaceutical clinical trials in the United States},
  author={A. Sertkaya and Hui-Hsing Wong and Amber Jessup and Trinidad Beleche},
  journal={Clinical Trials},
  pages={117 - 126}
  • A. Sertkaya, Hui-Hsing Wong, +1 author Trinidad Beleche
  • Published 2016
  • Medicine
  • Clinical Trials
  • Background: The increasing cost of clinical research has significant implications for public health, as it affects drug companies’ willingness to undertake clinical trials, which in turn limits patient access to novel treatments. [...] Key Method We evaluated per-study costs across therapeutic areas by aggregating detailed (per patient and per site) cost information. We also compared average expenditures on cost drivers with the use of weighted mean and standard deviation statistics. Results: Therapeutic area…Expand Abstract
    138 Citations

    Figures, Tables, and Topics from this paper.

    Explore Further: Topics Discussed in This Paper

    Closing the cycle of innovation in healthcare in Europe.
    • 1
    Registry-based trials: a potential model for cost savings?
    Should the United States government regulate prescription prices? A critical review.


    The costs of conducting clinical research.
    • 131
    Sensible approaches for reducing clinical trial costs
    • 137
    Assessing the Impact of Protocol Design Changes on Clinical Trial Performance
    • 115
    • PDF
    The price of innovation: new estimates of drug development costs.
    • 3,794
    • Highly Influential
    • PDF
    Impediments to Clinical Research in the United States
    • 39
    • Highly Influential
    Risk-Based Source Data Verification Approaches: Pros and Cons
    • 35
    Rapidly rising clinical trial costs worry researchers
    • R. Collier
    • Medicine
    • Canadian Medical Association Journal
    • 2009
    • 71
    • PDF